Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Other liabilities (Details)

Other liabilities (Details) (USD $)	Jan. 31, 2015	Jul. 31, 2014
Other liabilities (Details) [Line Items]
Other Liabilities, Current	$ 830,000us-gaap_OtherLiabilitiesCurrent	$ 790,000us-gaap_OtherLiabilitiesCurrent
Accrued Legal Settlement	1,200,000enz_AccruedLegalSettlement
Capital Lease Obligation [Member] \| Clinical Labs [Member]
Other liabilities (Details) [Line Items]
Capital Leases, Future Minimum Payments, Interest Included in Payments	45,000
Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments	567,000
Other Liabilities, Current	149,000
Installment Loans [Member] \| Clinical Labs [Member]
Other liabilities (Details) [Line Items]
Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments	575,000
Other Liabilities, Current	$ 281,000

- Definition

Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.

+ References + Details